The Laser in Glaucoma and Ocular Hypertension trial evaluated the effectiveness of selective laser trabeculoplasty (SLT) as a secondary treatment for open-angle glaucoma and ocular hypertension. The study found that SLT reduced the need for medication while providing additional intraocular pressure control, potentially offering a cost-effective solution for the NHS. However, while SLT proved beneficial for stable cases, it may not eliminate the need for definitive surgical intervention in advanced disease.

Source: JAMA Ophthalmology